Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.

Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, Porter LH, Niranjan B, Whitby ST, Lo J, Huang C, Schittenhelm RB, Anderson KE, Furic L, Wijayaratne PR, Matzaris M, Montgomery MK, Papargiris M, Norden S, Febbraio M, Risbridger GP, Frydenberg M, Nomura DK, Taylor RA.

Sci Transl Med. 2019 Feb 6;11(478). pii: eaau5758. doi: 10.1126/scitranslmed.aau5758.

PMID:
30728288
2.

Exogenous lipids promote the growth of breast cancer cells via CD36.

Zhao J, Zhi Z, Wang C, Xing H, Song G, Yu X, Zhu Y, Wang X, Zhang X, Di Y.

Oncol Rep. 2017 Oct;38(4):2105-2115. doi: 10.3892/or.2017.5864. Epub 2017 Aug 1.

3.

Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.

Li L, Che L, Tharp KM, Park HM, Pilo MG, Cao D, Cigliano A, Latte G, Xu Z, Ribback S, Dombrowski F, Evert M, Gores GJ, Stahl A, Calvisi DF, Chen X.

Hepatology. 2016 Jun;63(6):1900-13. doi: 10.1002/hep.28508. Epub 2016 Mar 25.

4.

Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.

Bharadwaj KG, Hiyama Y, Hu Y, Huggins LA, Ramakrishnan R, Abumrad NA, Shulman GI, Blaner WS, Goldberg IJ.

J Biol Chem. 2010 Dec 3;285(49):37976-86. doi: 10.1074/jbc.M110.174458. Epub 2010 Sep 18.

5.

Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, de la Taille A, Culine S, Blancou H, Cristol JP, Michel F, Sardet C, Fajas L.

Mol Cancer Ther. 2010 Jun;9(6):1740-54. doi: 10.1158/1535-7163.MCT-09-1064. Epub 2010 Jun 8.

6.

Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts).

Ehehalt R, Sparla R, Kulaksiz H, Herrmann T, Füllekrug J, Stremmel W.

BMC Cell Biol. 2008 Aug 13;9:45. doi: 10.1186/1471-2121-9-45.

7.

Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.

Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA.

J Biol Chem. 2000 Oct 20;275(42):32523-9.

8.

Lipid metabolism in prostate cancer.

Wu X, Daniels G, Lee P, Monaco ME.

Am J Clin Exp Urol. 2014 Jul 12;2(2):111-20. eCollection 2014. Review.

9.

Lipids and prostate cancer.

Suburu J, Chen YQ.

Prostaglandins Other Lipid Mediat. 2012 May;98(1-2):1-10. doi: 10.1016/j.prostaglandins.2012.03.003. Epub 2012 Apr 5. Review.

10.

Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.

Senga S, Kobayashi N, Kawaguchi K, Ando A, Fujii H.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1057-1067. doi: 10.1016/j.bbalip.2018.06.010. Epub 2018 Jun 12.

PMID:
29906613
11.

The role of CD36 in the regulation of myocardial lipid metabolism.

Kim TT, Dyck JR.

Biochim Biophys Acta. 2016 Oct;1861(10):1450-60. doi: 10.1016/j.bbalip.2016.03.018. Epub 2016 Mar 17. Review.

PMID:
26995462
12.

Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.

Swierczynski J, Hebanowska A, Sledzinski T.

World J Gastroenterol. 2014 Mar 7;20(9):2279-303. doi: 10.3748/wjg.v20.i9.2279. Review.

13.

Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during ischemia and reperfusion.

Heather LC, Pates KM, Atherton HJ, Cole MA, Ball DR, Evans RD, Glatz JF, Luiken JJ, Griffin JL, Clarke K.

Circ Heart Fail. 2013 Sep 1;6(5):1058-66. doi: 10.1161/CIRCHEARTFAILURE.112.000342. Epub 2013 Aug 12.

PMID:
23940308
14.

Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization.

Glatz JF, Nabben M, Heather LC, Bonen A, Luiken JJ.

Biochim Biophys Acta. 2016 Oct;1861(10):1461-71. doi: 10.1016/j.bbalip.2016.04.008. Epub 2016 Apr 16. Review.

PMID:
27090938
15.

Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.

Cai H, Wu JS, Muzik O, Hsieh JT, Lee RJ, Peng F.

J Nucl Med. 2014 Apr;55(4):622-8. doi: 10.2967/jnumed.113.126979. Epub 2014 Mar 17.

16.

Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.

Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M.

Atherosclerosis. 2014 Jan;232(1):40-51. doi: 10.1016/j.atherosclerosis.2013.10.016. Epub 2013 Oct 31.

PMID:
24401215
17.

Emerging role of lipid metabolism alterations in Cancer stem cells.

Yi M, Li J, Chen S, Cai J, Ban Y, Peng Q, Zhou Y, Zeng Z, Peng S, Li X, Xiong W, Li G, Xiang B.

J Exp Clin Cancer Res. 2018 Jun 15;37(1):118. doi: 10.1186/s13046-018-0784-5. Review. Erratum in: J Exp Clin Cancer Res. 2018 Jul 16;37(1):155.

18.

A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36.

Momken I, Chabowski A, Dirkx E, Nabben M, Jain SS, McFarlan JT, Glatz JF, Luiken JJ, Bonen A.

Biochem J. 2017 Jan 1;474(1):149-162. doi: 10.1042/BCJ20160804. Epub 2016 Nov 8.

PMID:
27827305
19.

Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.

Singh KB, Kim SH, Hahm ER, Pore SK, Jacobs BL, Singh SV.

Carcinogenesis. 2018 May 28;39(6):826-837. doi: 10.1093/carcin/bgy051.

PMID:
29668854
20.

CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue.

Hajri T, Hall AM, Jensen DR, Pietka TA, Drover VA, Tao H, Eckel R, Abumrad NA.

Diabetes. 2007 Jul;56(7):1872-80. Epub 2007 Apr 17.

Supplemental Content

Support Center